NeoGenomics, Inc.
News
NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
Business Wire NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, will present three studies at the European Society for Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain...\n more…
Further weakness as NeoGenomics (NASDAQ:NEO) drops 3.8% this week, taking three-year losses to 69%
Simply Wall St Research NeoGenomics' (Nasdaq:NEO) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.\n more…
Maryland State Retirement & Pension System Has $618,000 Holdings in NeoGenomics, Inc. (NASDAQ:NEO)
Ticker Report Maryland State Retirement Pension System lessened its stake in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 3.9% in the second quarter, HoldingsChannel reports. The firm owned 44,528 shares...\n more…
NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Business Wire NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, will attend the Morgan Stanley 22nd Annual Global Healthcare Conference. Chris Smith, Chief Executive Officer, Jeff...\n more…
Blue Trust Inc. Raises Stake in NeoGenomics, Inc. (NASDAQ:NEO)
Ticker Report Blue Trust Inc. boosted its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 107.2% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm...\n more…